2012 Annual Report

THE FACTS

  • 100% ownership by Abano
  • Hold and maintain strategy
  • Seven locations around New Zealand plus visiting clinics in outlying areas
  • 70 staff including 28 clinicians

THE YEAR IN REVIEW

The Orthotic Centre is New Zealand's foremost supplier of orthotic services and specialist products with locations in Auckland, Hamilton, Wellington, Christchurch, Invercargill and Dunedin. The company derives its income primarily from private sales, ACC and DHB contracts, and referrals from medical specialists, general practitioners and other health professionals. The Orthotic Centre has major manufacturing facilities in Auckland and Christchurch, as well as smaller facilities in Dunedin and Wellington, which specialise in custom-made orthoses and orthotic footwear. As well as manufacturing for its own clinical services, Orthotic Centre also provides a manufacturing base for servicing other providers throughout the country. 

A number of DHB contracts have been reviewed and negotiated over the past year, and the primary focus was on building relationships with funders, to ensure the service provided meets both the requirements of the funder and the needs of clients.

For the first time in a number of years, the business achieved a full complement of clinical orthotists. There is no orthotist training in New Zealand and, therefore, all clinical orthotists must be recruited from overseas.

FY12 Highlights

  • Signed new acute service contract with Capital & Coast DHB in May 2012
  • Focus on consolidating the South Island businesses into the group
  • Standardised product purchase across the group
  • Introduced quality plan to South Island facilities
  • Ongoing implementation and trial of new patient management system, to provide improved reporting and patient information
  • Continued investment into infrastructure and improving operational efficiencies
  • Inaugural clinical conference held in February 2012, with very positive feedback from attendees.

LOOKING FORWARD

The focus will be on ongoing contract negotiation and renewal. Management will be working with DHBs throughout the year as they review their requirements and the best way forward for funding and service provision.

Goals FY13

  • De-risk the company from DHB tenders for existing work
  • Explore diversification investment opportunities to widen the sources of revenue
  • Identify, nurture and develop leadership and clinical talent across the business through effective reward and recognition programmes
  • Complete the implementation of the new patient management system
  • Maximise and improve gross margins through product and supplier negotiations and strategic partnerships.